Glycoprotein IIb/IIIa Inhibitors Versus Standard Therapy in Patients With Myocardial Infarction and No-reflow
Status:
Unknown status
Trial end date:
2020-08-01
Target enrollment:
Participant gender:
Summary
Aim of the study is to examine the effects of glycoprotein IIb/IIIa inhibitors on reperfusion
success assessed by cardiac magnetic resonance imaging in patients with myocardial infarction
and angiographic evidence of no-reflow.